Diego Vergaças de Sousa Carvalho

Dr. Diego Vergaças de Sousa Carvalho

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
CSCarla Daruich de Souza
Carla Daruich de Souza
ABAngélica Bueno Barbezan
Angélica Bueno Barbezan
WRWILMMER ALEXANDER ARCOS ROSERO
WILMMER ALEXANDER ARCOS ROSERO
SSSofia Nascimento Dos Santos
Sofia Nascimento Dos Santos
DCDiego Vergaças de Sousa Carvalho
Diego Vergaças de Sousa Carvalho
MRMaria Elisa Chuery Martins Rostelato
Maria Elisa Chuery Martins Rostelato
New forms of cancer treatment, which are effective, have simple manufacturing processes, and easily transportable, are of the utmost necessity. In this work, a methodology for the synthesis of radioactive Gold-198 nanoparticles without the use of surfactants was described. The nuclear activated Gold-198 foils were transformed into H198AuCl4 by dissolution using aqua regia, following a set of steps in a specially designed leak-tight setup. Gold-198 nanoparticles were synthesized using a citrate reduction stabilized with PEG. In addition, TEM results for the non-radioactive product presented an average size of 11.0 nm. The DLS and results for the radioactive 198AuNPs presented an average size of 8.7 nm. Moreover, the DLS results for the PEG-198AuNPs presented a 32.6 nm average size. Cell line tests showed no cytotoxic effect in any period and the concentrations were evaluated. Furthermore, in vivo testing showed a high biological uptake in the tumor and a cancer growth arrest.